Most Recent
The Australian Patent Office has shot down a patent application covering throat lozenges by consumer goods giant Reckitt-Benckiser on a challenge by rival Sanofi-Aventis.
Squire Patton Boggs has brought a shareholder class action worth potentially $300 million against logistics software company GetSwift and its director, former AFL player Joel MacDonald, for providing inadequate disclosures and misleading investors with “overhyped” announcements about business contracts.
A Slater and Gordon lawyer representing three unions seeking Fair Work Commission approval for a proposed tie-up, has slammed an "urgent" email from counsel at Herbert Smith Freehills claiming a newly discovered contempt matter involving one of the deal's applicants should bar approval of the deal.
Toll Global has been fined $75,000 after pleading guilty to transporting over 16,000 kilograms of expandable and flammable polymer beads by truck.
A Fitbit suit challenging two trademarks owned by South Australian convenience store king Yasser Shahin should be moved to South Australia, Shahin has told a court.
S&P Global Ratings has reached a settlement in an Australian class action by investors who bought toxic products rated healthy by the U.S. credit reporting agency ahead of the global financial crisis, a deal that includes over $4.6 million in legal fees.
The Full Federal Court will hear arguments Monday from Prysmian Cavi E Sistemi that a $3.5 million fine handed down in a case brought by Australia’s competition regulator for alleged cartel conduct should be tossed out.
A judge in the Supreme Court of Victoria hearing a case brought by Cargill Australia alleging fraudulent concealment in the $420 million sale of malt producer Joe White Maltings by Viterra Malt Pty Ltd won't loosen the reins on lawyers who have spent "millions of dollars" on discovery.
Drug giants GlaxoSmithKline and Novartis have conceded part of the ACCC's case that packaging on their Voltaren Osteo Gel breached the Australian Consumer Law, but said the label was changed almost a year ago.
The judge who sided with Medibank in the ACCC's failed case last year paid little attention to one of the consumer regulator's central arguments against the private health insurer, a court heard Monday.